• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Syndromic Testing Markets

$2,500.00 – $5,000.00

Clear
SKU: 19-094 Category: Diagnostics Market Research Tags: GI Syndromic Tests, HAI Syndromic Test, Respiratory Syndromic Tests, Syndromic Test Panels Pages: 37
  • Description
  • Table of Contents
  • Latest reports

Description

Saving sample volume, cutting down provider time, reducing costs, improving outcomes, these are goals of the healthcare system, and they are well suited to a test that can identify more than a single pathogen. It has been thought that numerous pathogens tested directly from clinical specimens could change up diagnostics, and many vendors have responded by producing syndromic multiplex panels with considerable capabilities. These single tests, designed to detect a number of organisms that might have caused a particular syndrome, are aimed at positively influencing decisions regarding patient management, infection control, and antimicrobial prescription decisions. On a more fundamental level- they can produce better test results, as they tend to find infections at a greater rate.

This Kalorama Information report includes the following important business data:

  • Selected Syndromic Test Panels
  • Market for GI Syndromic Tests
  • Market for Respiratory Syndromic Tests
  • Market for HAI Syndromic Test Panels
  • Market for Other Syndromic Testing
  • Forecasts to 2023
  • Company Profiles

It is increasingly common to test in panels to gain clarity on disease while treatment will be most effective. Numerous multiplex products are on the market, and their effectiveness has been shown in studies, but there are challenges with reimbursement. Syndromic tests offer benefits and many studies prove their worth, but there are challenges. The tests by nature test for more than the disease-causing pathogen and can increase overall costs. Despite this, used right they can lower costs. There is a substantial market and it is expected that as workarounds for the new payor issues are developed growth can proceed. These issues are covered in this report.

As of 2019, over 40 companies are active in the global market for liquid biopsy diagnostics and monitoring tests. The market for liquid biopsy testing, still in its infancy, is rapidly evolving as vendors develop and commercialize innovative new technologies to meet the needs of the clinical diagnostic market.

Geographically, the majority of participants in the liquid biopsy market are based in the United States, and to a lesser extent, Europe. A few companies are based in Asia. The competitive landscape is quite varied, with participants ranging from some of the world’s largest and most well-established diagnostics companies, to small start-ups.   Kalorama’s report provides extensive landscaping

With the growing number of market entrants and available tests, competition is increasing. In the past two years, several new competitors entered the market, while several others have exited. However, with the rapidly growing market the heterogeneity of cancer as an umbrella term for many diseases, there are ample opportunities in the market to meet the needs of clinicians and patients.  Kalorama’s report tracks these trends, identifies segment markets and separates research markets from those involving the detection and monitoring of disease.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Syndromic Testing
  • Advantages
  • Challenges
  • Scope/Methodology
  • Size and Growth in the Market
    • Figure 1-1: Market for Syndromic Testing, 2018 – 2023

Chapter Two: Market Summary

  • Vendor Activity
    • Table 2-1: Selected Syndromic Test Platforms
  • Recent Developments in Syndromic Testintg
  • Continued Unnecessary Antibiotic Prescription Use
  • Large Elderly and Immunocompromised Population
  • Meridian Enters Syndromic With GenePOC Acquisition
  • Positive Studies Demonstrate Benefits
  • Mixed Infections
  • Rising Foodborne Infections
  • Size of the Market by Indication
    • HAI
    • GI
    • Resp.
    • Other
  • Table 2-2: Syndromic Testing by Type (HAI, Respiratory, GI Testing, Others) 2018-2023 [millions]
  • Syndromic Testing Post-Palmetto Decision

Chapter Three: Corporate Profiles

  • Abbot
  • Akonni Biosystems
  • Becton, Dickinson and Company
  • Biocartis
  • Biomerieux/BioFire
  • Luminex
  • Meridian Bioscience
  • Qiagen
  • Siemens Healthineers
    In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028
    September 22, 2023
    The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition
    August 24, 2023
    30-Country IVD Market Atlas (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
    August 21, 2023
    At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), 2023
    June 6, 2023

Related products

  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume I: Prion Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    U.S. Market for Molecular Diagnostics, 2nd Edition

    $3,500.00 – $7,000.00
  • Placeholder image

    Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

    $1,500.00 – $5,990.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The World Liquid Biopsy MarketThe World Molecular Diagnostics Market, 8th Edition
Scroll to top